WHO ICTRP trial
Diclofenac for pulmonary embolism
EUCTR2012-000247-27-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-000247-27-ES |
|---|---|
| Public title | Diclofenac for pulmonary embolism |
| Scientific title | Clinical benefit of diclofenac in patients with acute submassive pulmonary embolism: a randomized clinical trial |
| Primary sponsor | Fundación Investigación Hospital Ramón y Cajal |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Spain |
| Conditions | Acute pulmonary embolism MedDRA version: 14.1 Level: PT Classification code 10037377 Term: Pulmonary embolism System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Cardiovascular… |
| Interventions | Trade Name: Voltaren Pharmaceutical Form: Solution for infusion INN or Proposed INN: DICLOFENAC CAS Number: 15307-86-5 Other descriptive name: VOLTAREN Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 75… |
| Registration date | Jan 31, 2012 |
| Secondary IDs | AINEP |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: